Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Teliso-V
Teliso-V
AbbVie seeks FDA approval for non-small cell lung cancer treatment
Pharmaceutical Business Review
Mon, 09/30/24 - 09:45 am
AbbVie
FDA
Teliso-V
non-small cell lung cancer
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena
Mon, 06/3/24 - 12:06 pm
ASCO 2024
AbbVie
antibody-drug conjugates
Teliso-V
ABBV-400
ABBV-706
solid tumors
AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval
BioSpace
Fri, 12/1/23 - 11:23 am
AbbVie
Teliso-V
antibody-drug conjugate
non-small cell lung cancer
AbbVie cues up filing for c-Met ADC in lung cancer
Pharmaphorum
Wed, 11/29/23 - 12:00 pm
AbbVie
Teliso-V
clinical trials
lung cancer
FDA grants breakthrough designation to AbbVie’s Teliso-V for NSCLC treatment
Pharmaceutical Business Review
Wed, 01/5/22 - 10:33 am
FDA
AbbVie
Teliso-V
telisotuzumab vedotin
non-small cell lung cancer
